Drug: VIRAMUNE Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 26 Number of Pages: 2
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
119152992 | VIRAMUNE | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | F | 2 KG | 20160825 | DE |
119162782 | VIRAMUNE | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | F | 1 KG | 20160825 | US |
119258642 | VIRAMUNE | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | M | 2 KG | 20160829 | FR |
119281626 | VIRAMUNE | Foetal exposure during pregnancy | VIIV | 0.00 | M | 3 KG | 20160927 | GB |
119324813 | VIRAMUNE | Foetal exposure during pregnancy | BOEHRINGER INGELHEIM | 0.00 | M | 3 KG | 20160926 | GB |
635651610 | VIRAMUNE | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 YR | F | 1 KG | 20160825 | US |
Total Records: 26 Number of Pages: 2